AYVAKIT

The body factory

Concepting / Copywriting / Production

To help patients understand how AYVAKIT works, we created “The Body Factory,” a helpful metaphor that showcases what happens inside the body when someone has ISM and takes AYVAKIT to treat their symptoms.

AGENCY: FCB Chicago

OVERVIEW

In May 2024, AYVAKIT launched as the first and only FDA-approved treatment for adults with indolent systemic mastocytosis (ISM). In 2025, we created “The Body Factory” to help patients understand how this treatment works differently from over-the-counter medications by targeting the source of ISM to reduce symptoms.

A smiling woman with long dark hair and gold hoop earrings, sitting with others, blurred in the background.
A woman sitting on a sofa, looking contemplative, in a living room with sunlight coming through curtains.

SOCIAL

We figured out how to reach our patient audience on social media creatively (and within regulatory guidelines) and help them understand how AYVAKIT can help treat this rare disease.

Facebook ad for AYVAKIT avapritinib showing information about reaching systemic mastocytosis symptom relief goals, with images of groups of people outdoors and text highlighting AYVAKIT's effectiveness
Screenshots of a Facebook ad for AYVAKIT avapritinib, showing promotional text and images of a woman and a doctor, with links to learn more about the medication.
Next Project: Selva
Next Project: Selva
Back to Project Page
Back to Project Page